Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on July 22, 2025
5th Annual State of Menopause Study, Long-Running Survey of Menopausal Women in US, Reveals Perimenopause May be Most Misunderstood Health Transition
GlobeNewswire
·
July 22, 2025
New York, NY, July 22, 2025 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a women’s healthcare company that provides hormone-free, clinically researched solutions to effectively relieve perimenopause …
Outlook Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
Video webcast now available on-demand ISELIN, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, …
Akari Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
BOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced Abizer …
Kaida BioPharma Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
– Video webcast now available on-demand FORT LAUDERDALE, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated to advancing targeted anti-cancer therapies to address hormone-driven …
Moleculin Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
– Video webcast now available on-demand HOUSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to- …
Autonomix Medical, Inc. Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
– Video webcast now available on-demand THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how …
GRI Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
– Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the …
Senti Biosciences Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
– Video webcast now available on-demand Carlsbad, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel …
SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery
GlobeNewswire
·
July 22, 2025
Performed by Dr. Sudhir Srivastava utilizing the Company’s SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France, at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India FORT …
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
GlobeNewswire
·
July 22, 2025
WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to announce the extinguishment of its convertible note with YA …
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
GlobeNewswire
·
July 22, 2025
Ra’anana, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced encouraging preclinical results supporting the …
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
GlobeNewswire
·
July 22, 2025
IRVINE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will host its inaugural Lap-Band® Surgeon Summit, taking place August 1 …
Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call
GlobeNewswire
·
July 22, 2025
MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, …
$717.3 Billion by 2032: Why Digital Stethoscopes Are Transforming Modern Diagnostics | MarketsandMarkets™
GlobeNewswire
·
July 22, 2025
Delray Beach, FL, July 22, 2025 (GLOBE NEWSWIRE) -- What’s Fueling the Shift from Analog to AI-Powered Auscultation? The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance …
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
GlobeNewswire
·
July 22, 2025
BRISBANE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life- …
Veru to Participate in the 2025 BTIG Virtual Biotech Conference
GlobeNewswire
·
July 22, 2025
MIAMI, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that the …
InStride Health Strengthens Executive Team with Appointment of Chief Commercial Officer and Chief Financial Officer
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- InStride Health, a leading insurance-based provider of specialty anxiety and obsessive-compulsive disorder (OCD) treatment for children, adolescents and young adults, today announced the appointment of Don LeBlanc …
LOBO EV (NASDAQ: LOBO) Unveils $3 Million Annual Revenue Opportunity with AI-Powered Senior Mobility Robot Launching October 2025
GlobeNewswire
·
July 22, 2025
WUXI, China, July 22, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (NASDAQ: LOBO) (“LOBO” or the “Company”), a leading manufacturer and innovator in electric mobility and intelligent systems, today announced a strategic partnership with the Jiangsu …
Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds
GlobeNewswire
·
July 22, 2025
THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into agreements …